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1 Introduction and scope of the mission  
This is the report of the 1st mission to Egypt for the project: Impact of brucellosis and tuberculosis on 
animal production and public health (BO;10;009;118). 
The objective of this mission was: to make an assessment of the current needs and problems in Egypt 
related to brucellosis and tuberculosis and to get to know the main stakeholders. 
In practice an important objective of the mission was to make contacts with the main stakeholders in the 
Ministry of Health and Population (MHP) and the Ministry of Agriculture and Land Reclamation (MALR) and 
to investigate their interests in joining forces to design and develop a project on the control of brucellosis 
and tuberculosis.  
During the implementation of the EU Twinning Project on veterinary services Frits van Vugt had already a 
good relationship with MALR, especially the GOVS (Government Organization for Veterinary Services) but 
contacts with the MHP had yet to be established. The basic idea for the  project had to be introduced and 
explained to the main stakeholders. 
The EU Twinning project for the Veterinary Services has been working in Egypt for 2 years and developed 
a national Strategic Plan for Animal Health. Based on the results of a workshop (May 2010) in which also 
the MHP participated brucellosis and tuberculosis were among the priority diseases which urgently needed 
more attention and improved control strategies. The Agriculture Office of the Netherlands Embassy in 
Egypt made seed money available for a 2 year preparation project to assess the impact of brucellosis and 
tuberculosis, to stimulate the collaboration between MALR and MHP for the control of zoonoses and to 
develop and design a project especially for control of these diseases. 
Transboundary emerging zoonoses and other animal diseases pose increasing risks to animal production, 
public health, food security, income, and international trade in animal products. Particular threats for Egypt 
are coming from epidemic diseases such as Avian Influenza, and Rift Valley Fever but also from endemic 
diseases like brucellosis and tuberculosis. Several initiatives form international organizations like FAO, 
WHO and UNDP address HPAI and Rift Valley Fever, but tuberculosis and brucellosis are neglected 
diseases and their impact tends to be underestimated in Egypt. At the same time the Government of Egypt 
has prioritized the development of the dairy sector, which largely consists of smallholders with 2;10 
animals. Milk from these smallholders is unprocessed often used for home consumption or traded through 
informal channels to consumers in the neighborhood. Growth of informal trade in unprocessed milk 
increases the risks of these diseases resulting in a negative impact on animal production and on the health 
of farmers, workers and the general public. 
Control of brucellosis and tuberculosis requires an integrated approach where the human health services 
and the animal health services collaborate and join forces in the development of control policies and 
strategies for implementation. Such an integrated approach in zoonoses control forms the backbone of  
“One Health” concept promoted by international organizations (WHO, OIE and FAO). Working together 
under the “One Health” concept has potentially many advantages e.g. in making an estimate of the impact 
on animal production and on public health to support adequate and appropriate resource allocation. 
Through exchange of information and joining forces disease hotspots can be easier identified and 
controlled. Medical and veterinary professionals need to know the complete disease cycle, the role of 
animals and animal products and be able to integrate data collected from animals and humans. Similarly 
effective control might require inputs from the medical and the veterinary sectors or a coordinated joint 
effort. However, notwithstanding the logic of the “One Health” concept and the obvious need for 
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intersectoral collaboration in the control of zoonoses with the aim to reduce economic losses and human 
suffering, so far effective collaboration in most countries is rare.  
Both the Ministry of Agriculture and Land Reclamation (MALR) and the Ministry of Public Health are facing 
the challenges in preventing, controlling and reducing the impact of zoonoses. Such a "One Health" 
integrated veterinary – public health approach is rather novel in Egypt. For control of brucellosis and 
tuberculosis it needs to start with assessing the impact and risks of these diseases for animals as well as 
for humans. This should be followed by a joint formulation of relevant policies and planning of 
implementation. Not only collaboration of veterinary services and human health services is required but 
also intensive cooperation with the other stakeholders is paramount. These diseases can only be 
effectively tackled in an integrated approach. 
 
 
 Discussions during the mission 3 
2 Discussions during the mission  
During the mission we met with the following people:  
 
Dr Omar Abdin Executive Director Ministerial group for Agricultural Policies  
and Projects, Ministry of Finance  
Prof Dr Hasan Shafik Mohamed Osman Chairman of the General Organization for Veterinary 
Services (GOVS), Ministry of Agriculture and Land 
Reclamation 
Dr Amr Kandeel First Undersecretary, Chief of Cabinet, Minister’s Office, 
Ministry of Health and Population 
Dr Mohamed Galal Director Animal Health Research Institute 
Dr Ir Hans van der Beek Counselor for Agriculture, Nature and Food Quality, 
Embassy of the Netherlands (participated in most 
discussions) 
Dr Ahmed Maher Wally Senior Policy officer Economic Affairs, Agriculture and 
Innovation, Embassy of the Netherlands (participated in all 
discussions) 
Broer van der Meer Resident Twinning Advisor, EU Twinning Project for GOVS 
 
In view of the main priorities in the animal disease control agenda and the sustainability of the project 
results several meetings were held with representatives from different organisations in the Egyptian 
government. The issue pursued were especially the set;up of a coordinated effort to control the zoonoses: 
brucellosis and tuberculosis. 
From Netherlands side the objective of the (BOCI) project plan for brucellosis and tuberculosis was 
introduced. It was explained that the key issue would be to reach an integrated approach from both the 
veterinary and the public health authorities in Egypt. It will be important to draw up a risk based approach 
to the brucellosis and tuberculosis situation in Egypt, analyse jointly with the relevant stakeholders what 
the main risks involved are and how to tackle them. The zoonosis aspect is less likely to be a high risk in 
the sector of the large scale milk producers (organised in EMPA), because the milk is delivered to dairy 
plants and heat treated before marketing to the consumer. However also from their animals the low 
producing cull cows may be sold on the market to small farmers and especially these animals could be the 
risk animals regarding the diseases. The importance of the diseases was also discussed in relation to the 
insidious character: both tuberculosis and brucellosis infections in humans may give rise to long duration 
illness that severely affects health, welfare and productivity of the patients, without giving rise to obvious 
high acute death rates. This makes the diseases less ‘visible’ and as a result they may receive less 
attention and priority. In fact brucellosis and tuberculosis may become “new” emerging diseases because 
of the development of antibiotic resistance. In the future they may prove to become uncontrollable, 
notwithstanding the fact that the diseases are known already for a long time!  
The first meeting took place with dr Omar Abdin, from the Ministry of Finance. Dr Abdin recollected his 
activities to support small and medium scale dairy farmers. A project which he initiated and is still actively 
involved with.  
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Dr Abdin shared the objectives and agreed with the need for an integrated approach, he commented that 
it is important to work towards tangible results on the shortest possible term. This will be needed to gain 
sustainable support from the Egyptian authorities. He suggested to develop in the project a proposal for a 
“pilot” scale project, that would be implemented by a private manager or company. To this implementer 
the necessary instruments in government hands should be made available: like vaccines, diagnostic 
capacity, veterinary support etc. The clients of such project would be MHP and MALR. An important point 
of attention is to assure confidence with the farmers and producers to cooperate and participate. 
A pilot area may be one or more governorates that respond to specific characteristics or it may be a 
region. Adequate and meticulous identification, registration and movement control are basic elements for 
such a pilot region. 
The Chairman of GOVS, dr Hassan Shafik, underlined the importance of a coordinated approach between 
GOVS and the human health authorities. He welcomed the idea of a project initiative to support and 
facilitate the set;up of a coordinated effort between both Ministries. 
Dr Hassan Shafik immediately contacted his counterpart in the Ministry of Health to organise a further 
meeting for the mission team (we got an appointment for the next day). 
Dr Hassan Shafik outlined the vaccination policy of GOVS, however the activities are hampered by lack of 
adequate funds. This results in incomplete vaccination coverage. Also the limited compensation to the 
farmers for condemned animals and materials is seriously compromising the efficacy of the control 
programs. He also underlined the importance of an adequate animal identification and movement control 
system as a prerequisite for adequate control of brucellosis and tuberculosis. It is concluded that there 
are serious defects in the control of the diseases. A strategy, which is well coordinated between the 
veterinary and human health authorities, would be an important step forward. The development of such 
strategy would also be an asset to improve the chances for obtaining adequate funding from either 
internal (Egyptian) or external (international) donors.  
Dr Hassan Shafik also points to rabies as an important zoonosis, that requires a coordinated approach 
from public health and veterinary authorities. Rabies is a serious risk in Egypt (bites from stray dogs). 
Note: 
Dr Hans van der Beek invited dr Hassan Shafik for a visit to the Netherlands, which could take place 
presumably in May next. Dr van der Beek will send a formal invitation for dr Hassan Shafik and he is invited 
to take a colleague along with him. Dr van der Beek will also present a proposal for the issues to be 
covered during the visit. The objective of the visit would be to give dr Shafik an outline of the veterinary 
organisational structure in The Netherlands.     
The meeting with dr Amr Kandeel, first undersecretary and Chief of Minister’s Cabinet at MHP proved 
very useful. Dr Kandeel is very interested in the BOCI project proposal and whole;heartedly supports the 
plan to bring together the relevant authorities and stakeholders on brucellosis and tuberculosis. Dr 
Kandeel is personally involved in the brucellosis issue and he mentions that about 5000 positive cases per 
year are found in Egypt in humans. Further information would be available for the project in due course. On 
tuberculosis he has no data by heart, but he will arrange that in a next meeting a colleague of the same 
Ministry will be available who is well informed on tuberculosis. For both diseases no accurate data are 
available because there is no systematic surveillance taking place. Analyses are performed on incidents 
and suspicions that arise. Tuberculosis falls under the responsibility of another department within the 
Ministry. 
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Dr Kandeel shares the view that both issues, tuberculosis and brucellosis should be attacked in a 
coordinated way between human health and veterinary officials. He also shares the view that these two 
diseases have in common that raw milk is an important risk factor.  
Dr Kandeel also draws the attention to RVF (Rift Valley Fever) and rabies as important zoonotic risks, 
where cooperation between human health and veterinary authorities should benefit from each other and 
should find a coordinated approach. However, he acknowledges that the project cannot take all on board. 
Dr Kandeel mentions the CDC as an important source of data on disease occurrence. He also informs us 
that Egypt participates in the Global Fund  on Tuberculosis control (WHO). 
Dr van Vugt invites dr Kandeel to the Closing Conference in April of the EU Twinning project and it is 
agreed to find soon a date for further contact especially to talk about tuberculosis. Dr van Vugt will make 
general information on the Twinning project results available to dr Kandeel. 
At the Animal Health Research Institute (AHRI) located in Dokki the mission team met with the newly 
appointed Director, dr Mohamed Galal, and his staff. After the exchange of general information and 
introduction of the project outline, the staff of the Institute introduced their activities regarding tuberculosis 
and brucellosis. The Institute has standard testing for these diseases available and has in the country 
subordinated laboratories. For both diseases cooperation with the human health laboratories takes place 
on a sporadic and incidental basis, but not in a systematic way. In the discussion it is acknowledged that 
raw milk constitutes an important risk factor for both diseases’ transmission to humans. This regards the 
milk produced in the small scale and subsistence sector, but since this comprises 85% of Egyptian animal 
production the impact of this fact is tremendous. It is noted that this also means that the problem is 
difficult to tackle! 
With regard to tuberculosis it is noted that the percentage of tuberculosis infections in humans caused by 
Mycobacterium bovis is increasing as compared to the number of infections with M. tuberculosis. At 
present it is estimated that 10% of the tuberculosis cases in humans is caused by M. bovis. This 
communication underlines the importance of tuberculosis from animal origin for human health.  
It is concluded that the director of the AHRI together with his staff are very interested to participate in the 
BOCI;project activities.  
In the concluding meeting at the Netherlands Embassy the further development of the bilateral Egypt;
Netherlands project is discussed. 
The meetings with the Egyptian government officials clearly showed the keen interest from the veterinary 
and public health authorities to cooperate in the control of brucellosis and tuberculosis. They share the 
view that an integrated and coordinated approach will have an important added value to contribute to the 
control of these diseases in Egypt. They also share the view that the control of these diseases are linked 
through the risks involved in animal products, especially untreated milk and dairy products. The meetings 
clearly showed that the Egyptian counterparts welcome the catalytic role that the bilateral project with the 
Netherlands can play in the establishment of an integrated approach in the control of these diseases.   
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3 Follow;up and planned activities for 2011 
The objective of the bilateral cooperation project between Egypt and The Netherlands is to initiate and 
realise an integral strategic plan for the control and eventual eradication of brucellosis and tuberculosis for 
Egypt. Key issue for the strategic plan is the integral approach bringing together the coordinated input and 
control efforts of both MHP, MALR, government research institutes as well as the relevant stakeholders at 
private and NGO;level. The second important issue is to develop an effective,  coherent, well;focussed and 
integral control and eradication strategy for brucellosis and tuberculosis, which is based on sound 
technical knowledge, taking into account the local situation and national and international experience.  
The aim for 2011 is to make a shared risk analysis with all relevant stakeholders. Based on that shared 
risk analysis a coherent and coordinated strategy can be drawn up to be agreed by the Egyptian 
authorities. This should involve a detailed estimation of the impact of the disease and the damage caused 
to the Egyptian economy and from which a cost;benefit analysis can be made for an adequate eradication 
strategy. 
The process for realizing the integrated approach and effective strategy follows the risk analysis model, 
which is based on the three interrelated principles of risk assessment, risk management and risk 
communication (FAO, WHO).  
– The first step in the model is to make an assessment of the risks: starting with an overview of the 
factual information (incidence of the diseases, routes of transmission, evaluation of the information 
to identify and prioritise the risks involved). The risk assessment also involves an analysis of the 
possible options to control the risks and the feasibility of the control strategies. 
– The 2nd phase, the risk management phase then identifies which options are available for 
coordinated strategies to reach an effective control of the diseases and what are the bottlenecks 
and constraints for the implementation of the measures; 
– The third step the ‘communication’ phase initiates and interactive process of exchange of 
information and opinion based on the risk assessment and the risk management options between 
all relevant stakeholders. This could lead to further improving the risk assessment and the risk 
management components. 
 
To realise the integral strategic plan through the risk analysis process a two tier approach will be followed. 
The first activity is the organisation of a stakeholder workshop, which is scheduled for early June 2011. 
In this conference about 20 participants as representatives of the main stakeholders will be  brought 
together as an intensive think;tank. The workshop aims in a one;day process to make an inventory of the 
relevant issues pertinent to the integral control of both diseases in Egypt. The workshop has to make clear 
what is the added value that can be expected from a coordinated and integral strategic plan: on the basis 
of the joint discussions and sharing of views the conference will need to bring about a clear commitment 
of the key stakeholders to the coordinated strategic plan and ensure that they take ownership of the 
process.  
Presentations and topics to be discussed in the workshop: 
1. Presentations of factual information on the disease in men and animals, prevalence in the Egyptian 
context; 
2. Discussion on the evaluation of the information available and provided; 
3. Identification of the main risk factors in the Egyptian context. This concerns the risks of spreading of 
the disease and the transfer to the human population; 
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4. Identification of the main options for risk management in the animal and in the human area; 
5. Identification of bottlenecks and constraints as well as prerequisites in the strategy to overcome the 
disease; 
6. Formulation of an integral strategy to reach control and eventual eradication of the disease incl 
measurable indicators of progress. 
 
The workshop the beginning of June is shaped in the following program: 
09:00h  Opening and explanation of the program (AJ Nell) 
09:15h  Introduction into the substance, explanation of the objectives (FvVugt) 
09:30h Input from MALR;GOVS: data on prevalence of brucellosis and tuberculosis in the 
Egyptian animal population. (;;;) 
10:00h Input from Min of Health: data on prevalence of brucellosis and tuberculosis in the 
Egyptian human population (;;;) 
1030h  Introduction and instructions for the group discussions:  
; Evaluation of the data presented 
; Identification & prioritisation of the risks of transmission 
; Options to control the risks 
; Prioritisation of the control strategies 
; Analysis of the resources needed and the constraints 
 
10:45h  Group discussions (in two groups) together with coffee break 
12:00h  Reporting of group discussions 
12:30h  Summarising results of group discussions (FvVugt) 
13:00h  Plenary discussion & conclusion 
14:00h  Closure of working session 
14:30h  Lunch 
The results from the June workshop will be summarised in a discussion paper in the form of a draft risk 
analysis (risk assessment and risk management options). 
The second activity for 2011 will be a more extensive Conference planned for the end of September. 
The discussion paper prepared after the June Workshop on risk analysis and risk management will form 
the starting point of the conference. The Conference forms the communication phase of the risk analysis. 
The conference completes the risk analysis process and should further built and confirm ownership of the 
stakeholders for the integrated approach in a strategic plan and control programme to be developed 
during the second phase of the project.  
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Appendix 1 
Overview of policy relevant information regarding brucellosis and tuberculosis 
in Egypt  
The data presented below are a summary of general background knowledge as well as information 
received from the relevant Egyptian authorities. 
1 Brucellosis 
The disease is caused by infection with a bacterium and therefore has not a high spreading potential which 
is associated with viral diseases like Foot and Mouth Disease.  
The causative organism is primarily Brucella mellitensis1. This is originally mainly an infection in small 
ruminants but is now in Egypt also the main causing agent in large ruminants.  
It spreads from animal to animal through intrauterine infection and at birth. The organism is also present in 
adnexa (placenta etc.) and milk and it can be transferred to another animal (or a human being) through 
these materials.  Males do not normally play a role in the transmission of brucellosis. 
The animal health problem is: 
– loss of production as the result of abortion (loss of offspring); 
– loss of production capacity due to sickness of the animal. 
 
The human health risk arises from: 
– consumption of un;treated milk and milk products (cheese); 
– infection through contact (eventually consumption) of lymphatic organs and reproductive organs of 
infected animals. This is an occupational risk for farmers, butchers and veterinarians. 
 
The human health problem is: 
– a chronic debilitating disease with regular fever attacks that seriously affects health, well;being and 
productive capacity of the infected person; 
– economic loss due to reduced productivity and cost of treatment. 
Brucellosis in men is difficult to treat with antibiotics. 
When milk is pasteurised brucella bacteria are killed and in principle no problem exists. Large scale 
industrial producers will therefore not pose a risk because they produce for packed heat treated dairy 
products. However when these producers decide to cull animals due to low production, these animals may 
harbour the infection and therefore pose a risk to the next (often small scale) owner who uses the milk for 
home consumption and most likely also sells the milk untreated on the informal market. 
                                                     
 
1 In Egypt the first case of animal brucellosis was reported in 1939. Brucella abortus was isolated in cattle in 1943, but since 1970, 
Brucella mellitensis has been the more common species in large and small ruminants (Refaie, 1989). 
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WHO signals brucellosis as an important “forgotten” disease because it does not attracts the attention 
through large scale deaths in an epidemic. The human disease is a chronic and generally inconspicuous 
epidemic.  
Epidemiological data in men (data from Ministry of Health) 
The total number of cases notified2 is: 
Year cases 
2007 5120 
2008 5300 
2009 3969 
 
Geographical distribution: 
Five governorates notified the most important number of cases: Behira, Munufeya, Sharkyia, Fayoum and 
Minia.  
An older set of data on human prevalence: 
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
148 287 299 256 309 490 872 1006 ▪▪▪ ▪▪▪ 2902 
▪▪▪ : no information available 
The data suggest a considerable increase in human infections in the last decade. 
Epidemiological data in animals3 
 
Year Tested animals Positive % positive 
2005 339,850 2,945 0.87 
2006 360,167 2,289 0.64 
2007 331,716 2,264 0.68 
2008 394,246 3,893 0.99 
 
                                                     
 
2 The cases of brucellosis in humans have to be notified by the hospitals to the Ministry of Health. In practice notifications only come 
from governmental hospitals but not from private health centres, clinics and hospitals, so the prevalence in human populations is surely 
underestimated. 
3 There are as yet no reliable data on the total animal population. The total animal population according to census data in Egypt is 
about 8 million for cattle and buffaloes, and 4 million for small ruminants.   
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The highest incidence of brucellosis in animals occurs in the Nile Delta. 
About 90 % of the suspected sera samples are confirmed by the reference laboratory. 
Distribution over animal species of positive sera in 2007 and 20084: 
Year/species cow buffalo sheep goat positive tested 
2007 843 324 924 163 2264 331716 
2008 1177 238 965 672 3052 397054 
(discrepancy in total number and positives for 2008 is not explained) 
Brucellosis control program in animals: 
According to Egyptian regulation N°1329 from 1999, all female animals of the age of 6 months and more 
of cattle, buffaloes, sheep, goats, must be sampled and tested by BBAT and Rose Bengal tests. The 
positive animals are, after the analysis is confirmed by the National Reference Laboratory, slaughtered and 
(limited) compensation is given to the owner. Vaccination of young females is performed with Strain 19 for 
cattle, and Rev;1 for small ruminants, but only a small percentage of the animals concerned is vaccinated. 
The sampling program for Brucellosis is implemented depending on the availability of human and material 
resources. About 300,000 to 400,000  animals (all species in total) are tested each year which is less 
than 10% of all animals which need to be tested.  The lack of a systematic approach in selecting the 
animals for testing does not allow the calculation of brucellosis prevalence neither for flocks nor for 
animals, in fact the rate of positive animals/ tested animals, by governorates over 2008, varies from 0 % 
to 2.44 % which is expected to be underestimated. Different field surveys implemented in Egypt indicate a 
much higher prevalence. 
The question of the estimation of the prevalence in flocks and animals, by species and by governorates, is 
important: these data are necessary to perform an evaluation at medium and long term of the results of 
the control program. 
It should be noted that a considerable amount of data are obtained after sampling and analysis in case of 
incidents: suspicion of human infections. 
In case of sero;positive findings, the animal is slaughtered. Liver and lymphatic organs are removed from 
the carcass and destroyed. The rest of the carcass is in principle fit for consumption. The farmer is 
compensated with an amount of money defined in the law, and this represents about half the current 
market price of the animal. The owner is allowed to sell the rest of the carcass on the market. 
 
 
 
                                                     
 
4 These figures may be influenced by considerable underreporting in Egypt: 
- in animals there is no systematic surveillance (due to lack of funds) 
- Compensation of farmers (after identification of positive cases in test;and;slaughter programs) takes place only 
partly. Therefore there is considerable risk that farmers will not present suspected animals. 
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Compensations paid in three fiscal years are: (1 € = EGP 8) 
Fiscal year Compensation paid (EGP) 
2006/2007 2,092,550 
2007/2008 2,594,400 
2008/2009 2,649,250 
 
As a general measure preventive vaccination is applied for young animals. The vaccines are produced in 
the government laboratory in Abbassyia. For cattle and buffalo S19 vaccine is produced at a rate of about 
10,000 doses per year, for sheep and goats about 5,000 doses of Rev1. These vaccines are provided 
free of charge to small farmers and vaccination is done by GOVS veterinarians. Some large private farms 
import RB51 at a rate of about 15,000 doses per year. 
Since the amount of vaccine that becomes available is falling far short of the need, there is no systematic 
vaccination campaign. 
The need of vaccines against brucellosis on an annual basis is estimated at 1 Mio doses of S19 (for cattle 
and buffalo) and 1 Mio doses of Rev 1 (for sheep and goats). The present production capacity covers 
roughly a total of 15,000 doses. Two options exist to cater for the provision of vaccine in adequate 
amounts. 
– Upgrade the production capacity at the Abbassiya Vaccine Production Institute. This would require 
considerable investment in equipment (mainly for fermentation and lyophilisation) and in 
expertise/manpower; 
– Import the vaccines from outside sources; 
– Encourage production in the private sector by pharmaceutical companies. 
 
Each of these options will involve major investments and/or high annual cost. The Vaccine Production 
Institute needs to be modernised to increase production and guarantee quality; imported vaccines are 
expensive (around EGP 10 per dose); at present the potential of local pharmaceutical companies to 
produce the vaccine and antigen is unknown.   
2 Tuberculosis 
The disease is caused by a bacterium from the genus Mycobacterium. Several types exist but the most 
relevant in this context are Mycobacterium tuberculosis and M. bovis. Both types are pathogens for human 
beings. Mycobacteria can be transmitted from animals to man through air (cough and sneeze), through the 
ingestion of infected unheated milk and meat(products). It is noted that the fraction of M. bovis infections 
in the total of Mycobacterial infections in humans in Egypt is increasing (at present to about 10%).  
The animal health problem is: 
– loss of condition; 
– loss of production. 
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The human health risk arises from:  
– Consumption of unpasteurized milk and dairy products; 
– Transmission by air (mainly an occupational hazard for farmers, butchers and veterinarians); 
–  Transmission by air and contact human to human. 
 
The human health problem is: 
– Chronic disease severely affecting health and well;being and economic productivity. General 
sickness and loss of production capacity; 
– Economic loss through labour output and cost of medical treatment. 
Medical treatment is requires a one year course of antibiotics. 
No accurate data on the occurrence of tuberculosis in animals are available since there are no systematic 
surveillance programs. 
The number of positive cases in animals is very roughly estimated by the GOVS experts at about 0,3%.  
No regular testing of animals is taking place at the moment, only occasionally at an experimental basis.   
Large scale testing could be implemented  through skin test (tuberculin) and to some extent through meat 
inspection. Positive animals from the tuberculin test need to be culled, compensated for and slaughtered.  
Considering  that a considerable number of animals is not slaughtered under official control, a number of 
infections may go unnoticed and enter the food chain. In case of positive animals tracing of contact 
animals (and farmer’s family!) is important, but difficult for recently traded animals because of the lack of 
an adequate I&R system. 
In recent decades more and more international attention is paid to re;emergence of tuberculosis as an 
important disease because of the increased occurrence of antibiotic resistant strains. On the longer term 
this is a threat to human health on international scale.    
Egypt has a National Tuberculosis Programme (NTP) for control and treatment in humans, however in this 
programme not much attention is given to the prevention of infection from animals. In September 1997 
the National Board for TB Control was established by Ministerial Decree from the MHP and all departments 
and sectors involved in TB control in Egypt are represented: the NTP; Health Insurance Organization; 
Ministry of Interior; Ministry of Defence; Ministry of Education; Ministry of Higher Education; Ministry of 
Social Affairs; Ministry of Religious Affairs; the Coptic Church; Private Sector; Non;Governmental 
Organizations; and the Ministry of Agriculture. However, at present the MALR does not seem to be actively 
involved.  
The Netherlands has supported the National Tuberculosis Control programme for a period of 15 years 
from 1989 – 2003.  
Note:  
the mission was not able to speak to somebody in the MHP on tuberculosis; the right person was not 
available; more data and other information will be collected during a next visit of Frits van Vugt in April. 
More information on the National Tuberculosis Programme in Egypt on the websites: 
www.emro.who.int/stb/egypt/NTP_introd.htm 
www.usaid.gov/our_work/global_health/id/tuberculosis/countries/me/egypt_profile.html  
 
  
Centre for Development Innovation 
Wageningen UR 
P.O. Box 88 
6700 AB Wageningen 
The Netherlands 
 
This is the report of the 1st mission to Egypt for the project: Impact of brucellosis and tuberculosis on animal 
production and public health (BO;10;009;118). The objective of this mission was: to make an assessment of 
the current needs and problems in Egypt related to brucellosis and tuberculosis and to get to know the main 
stakeholders. 
 
More information: www.cdi.wur.nl 
 
